Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shangzhong0619
    Member
    • Nov 2013
    • 17

    #1

    HTseq-count feature type choice for RNAseq

    Hi all,
    I am using HTseq-count to count reads in my bam files. I used ncbi mouse annotation file.
    I wonder which feature type (third column of gff3 file) I should use?
    My understanding of how htseq count reads is that if I choose 'exon', then it will count reads only mapping to exons and sum those up for a gene. If I choose 'gene', it will count all the reads mapping to introns and exons of that gene. Theoretically, for RNAseq I should choose exons, and ignore reads mapping to introns.
    In my sample, I know I knock out the gene ext1. I tried both choices and used DEseq2 to do differential expression analysis. In my results which I chose the 'gene' feature, the ext1 gene was the most significant gene. However, in the results for choosing 'exon', there are over 200 genes more significant than ext1. So now I am confused, it seems that the 'gene' feature are better than 'exon'? Anyone has this situation before? thanks.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You'll want to use 'exon', otherwise you increase the noise from pre-mRNAs. I'm not sure why you would be disturbed to find other genes with more significant p-values than the knocked out gene. There are a few different things that affect one's ability to determine variance and the signal level (in this case, how highly expressed a gene is) is one of them. Since you're knocking the gene out, its expression should be very low in some of your samples (I'm assuming a complete knock out rather than just hemizygous), so you'll then have less power there to begin with. If this causes some other decently expressed gene to drastically increase expression then said other gene will probably have a smaller p-value. That's not really a problem.

    Comment

    • shangzhong0619
      Member
      • Nov 2013
      • 17

      #3
      Originally posted by dpryan View Post
      You'll want to use 'exon', otherwise you increase the noise from pre-mRNAs. I'm not sure why you would be disturbed to find other genes with more significant p-values than the knocked out gene. There are a few different things that affect one's ability to determine variance and the signal level (in this case, how highly expressed a gene is) is one of them. Since you're knocking the gene out, its expression should be very low in some of your samples (I'm assuming a complete knock out rather than just hemizygous), so you'll then have less power there to begin with. If this causes some other decently expressed gene to drastically increase expression then said other gene will probably have a smaller p-value. That's not really a problem.
      Hi, dpryan. Thanks for your reply. Actually my knock out is hemizygous, so in this case, it is possible to have genes more significant than the knock out gene?

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        Sure and for the reasons that I mentioned. Remember that the p-value just relates to believability of the finding given the data. Further, changes in biology are typically non-linear, so a 50% decrease in the knocked out gene could easily lead to larger changes in others. Not to mention that a hemizygous deletion will often not halve the expression.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        43 views
        0 reactions
        Last Post SEQadmin2  
        Working...